NASDAQ:IMTXW immatics biotechnologies (IMTXW) Stock Forecast, Price & News $3.58 -0.17 (-4.53%) (As of 09/21/2023 ET) Add Compare Share Share Today's Range$3.58▼$3.5850-Day Range$3.07▼$3.9152-Week Range$1.20▼$4.14Volume300 shsAverage Volume17,866 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsInstitutional OwnershipSEC FilingsShort InterestSocial MediaProfileChartCompetitorsFinancialsInstitutional OwnershipSEC FilingsShort InterestSocial Media About immatics biotechnologies (NASDAQ:IMTXW) Stockimmatics is a clinical-stage biopharmaceutical company active in the discovery and development of t-cell redirecting immunotherapies for the treatment of cancer. our transformative product candidates are - best in class - adoptive cell therapies and bispecific tcr molecules. these products are directed against tumor targets that have been identified and validated by immatics' proprietary and world-leading xpresident® technology. our mission is to bring the power of t-cell redirecting immunotherapies to cancer patients. quick facts - 150 team members - >100 targets covering 20 major solid and liquid tumors - about 80% of discovered targets are novel - 2 proprietary technology platforms - 8 proprietary development programs, thereof 2 in the clinic in 2017 - multiple partnered programs - raised more than $230m in cash in five financings read more about immatics on our homepage: https://immatics.com/ find us on twitter and xing: twitter: http://bit.ly/2dfbpre xing: http://bit.ly/2e1kkpv lRead More IMTXW Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IMTXW Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive IMTXW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for immatics biotechnologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Biological Product (except Diagnostic) Manufacturing Sub-IndustryN/A SectorManufacturing Current SymbolNASDAQ:IMTXW CUSIPN/A CIK1809196 Webimmatics.com Phone4970715397700FaxN/AEmployees381Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$84.86 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2023Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio. Get This Free Report Key CompetitorsJasper TherapeuticsNASDAQ:JSPRWSurrozenNASDAQ:SRZNW4D pharmaNASDAQ:LBPSWACE Convergence AcquisitionNASDAQ:ACEVWAdvent TechnologiesNASDAQ:ADNWWView All CompetitorsInstitutional OwnershipWalleye Capital LLCBought 53,153 shares on 8/15/2023Ownership: 0.000%Aristeia Capital LLCSold 116,708 shares on 8/14/2023Ownership: 0.000%683 Capital Management LLCSold 44,936 shares on 8/14/2023Ownership: 0.000%JPMorgan Chase & Co.Bought 40,168 shares on 8/11/2023Ownership: 0.000%Privium Fund Management B.V.Bought 448,043 shares on 7/26/2023Ownership: 0.000%View All Institutional Transactions IMTXW Stock - Frequently Asked Questions How have IMTXW shares performed in 2023? immatics biotechnologies' stock was trading at $2.51 at the start of the year. Since then, IMTXW stock has increased by 42.6% and is now trading at $3.58. View the best growth stocks for 2023 here. Are investors shorting immatics biotechnologies? immatics biotechnologies saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 14,100 shares, an increase of 15.6% from the August 15th total of 12,200 shares. Based on an average trading volume of 16,100 shares, the short-interest ratio is currently 0.9 days. View immatics biotechnologies' Short Interest. What is immatics biotechnologies' stock symbol? immatics biotechnologies trades on the NASDAQ under the ticker symbol "IMTXW." Who are immatics biotechnologies' major shareholders? immatics biotechnologies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Aristeia Capital LLC (0.00%), Privium Fund Management B.V. (0.00%), 683 Capital Management LLC (0.00%), JPMorgan Chase & Co. (0.00%) and Walleye Capital LLC (0.00%). How do I buy shares of immatics biotechnologies? Shares of IMTXW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is immatics biotechnologies' stock price today? One share of IMTXW stock can currently be purchased for approximately $3.58. How many employees does immatics biotechnologies have? The company employs 381 workers across the globe. How can I contact immatics biotechnologies? immatics biotechnologies' mailing address is Paul Ehrlich-Strasse 15, Tuebingen, Baden Wuerttemberg 72076. The official website for the company is immatics.com. The company can be reached via phone at 4970715397700. This page (NASDAQ:IMTXW) was last updated on 9/22/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding immatics biotechnologies GmbH Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.